<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander, Lori</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Cerqueira, Manuel</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Advances in Nuclear Cardiology</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">18-19</style></pages><abstract><style  face="normal" font="default" size="100%">This article provides an overview of pharmacologic stress agents, focusing on the identification and development of agents that can maximize overall laboratory efficiency and improve patient satisfaction. It also discusses the limitations of computed tomography angiography and myocardial perfusion imaging.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>